It is the goal of Hoag Cancer Center to offer revolutionary agents and innovative therapies in the fight against cancer. Through its
Cell Biology Laboratory, Hoag provides unique biotherapy trials, including vaccines, high-dose chemotherapy, and autologous activated lymphocytes and tumor infiltrating lymphoctes.
Additionally, Hoag has been host to nationally recognized pharmaceutical and biotechnology
clinical trials for immunotherapy, vaccines, monoclonal antibodies and radiolabeled monoclonal antibodies. The ability to provide groundbreaking clinical trials is yet another example of Hoag Cancer Center’s commitment to providing the highest level of cancer care to the community.
To learn more about Hoag’s research and clinical trials, please select from the following: